Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Oesophageal ulcer caused by aspirin |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 500 mg and glycine 133 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 500 mg and glycine 133 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing only aspirin and glycine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing only aspirin in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin- and glycine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin burn of oral mucosa |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin-induced angioedema-urticaria (disorder) |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin exacerbated respiratory disease |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Some |
4 |
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 81 mg and pravastatin 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 81 mg and pravastatin 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 81 mg and pravastatin 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 50 mg gastro-resistant oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 50 mg gastro-resistant oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 150 mg gastro-resistant oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 150 mg gastro-resistant oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin desensitisation therapy |
Using substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Product containing aspirin and atorvastatin and clopidogrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Product containing only aspirin and atorvastatin and clopidogrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 75 mg and atorvastatin (as atorvastatin calcium) 20 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin 75 mg and atorvastatin (as atorvastatin calcium) 20 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Aspirin- and atorvastatin- and clopidogrel-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Product containing only aspirin and atorvastatin and clopidogrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely aspirin 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Product containing aspirin and isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin and isosorbide mononitrate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin and glycine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 300 mg effervescent oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 300 mg effervescent oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and caffeine 15 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and caffeine 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing only aspirin and caffeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin- and caffeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Poisoning caused by aspirin (disorder) |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin- and glycine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing aspirin and clopidogrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin and clopidogrel only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 75 milligram and clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 75 milligram and clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin- and clopidogrel-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Aspirin and clopidogrel only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |